Applications: |
Immunodepletion/Immunocompetition |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Golgin A4 Blocking Peptide is synthetically produced from the 2025-2075 sequence and is suitable for use in western blot applications. |
Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
GOLGA4 |
Gene ID: |
2803 |
Uniprot ID: |
GOGA4_HUMAN |
Immunogen Region: |
2025-2075 |
Immunogen: |
Synthetic peptide taken within amino acid region 2025-2075 on human Golgin-245 protein. |
Function | Involved in vesicular trafficking at the Golgi apparatus level. May play a role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with MACF1. Involved in endosome-to-Golgi trafficking. |
Peptide Name | Golgin Subfamily A Member 4256 Kda GolginGolgin-245Protein 72.1Trans-Golgi P230 |
Database Links | Reactome: R-HSA-6811440Reactome: R-HSA-9673768 |
Cellular Localisation | CytoplasmGolgi Apparatus MembranePeripheral Membrane ProteinGolgi ApparatusTrans-Golgi Network Membrane |
Alternative Peptide Names | Golgin Subfamily A Member 4 protein256 Kda Golgin proteinGolgin-245 proteinProtein 72.1 proteinTrans-Golgi P230 proteinGOLGA4 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance